SciBac, Inc.
PrivateLast Round
Grant
Jul 9, 2019
Total Funding Raised
$1.32M
Company Overview
SciBac, Inc. operates in Healthcare & Life Sciences and is based in Burlingame, California. Its latest recorded funding round was a Grant round in July 2019.
SciBac, Inc. is a biotechnology company that develops live biotherapeutics designed to treat antibiotic-resistant infections by fortifying the human microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciBac, Inc. Comparables
Compare SciBac, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vedanta Biosciences | 81% | |
| Osel Inc. | 81% | |
| Exeliom Biosciences | 78% |
For institutional investors. Book with your work email.
SciBac, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2019 | ||||
| Grant | Jul 31, 2018 | ||||
| Accelerator | Apr 13, 2017 |
For institutional investors. Book with your work email.
SciBac, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Breakout Ventures | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2019
$287K grant received from the National Institutes of Health.
- Jul 31, 2018
$680K grant received from CARB-X.
For institutional investors. Book with your work email.
SciBac, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SciBac, Inc.'s valuation, stock price, and market status.
Is SciBac, Inc. a public or private company?
SciBac, Inc. is a private company.
What is the current stock price of SciBac, Inc.?
SciBac, Inc. is a private company, so its shares have no public market price. Caplight tracks SciBac, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SciBac, Inc. worth (valuation)?
Valuation information for SciBac, Inc. is not publicly available.
Can I buy SciBac, Inc. stock?
SciBac, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SciBac, Inc.'s last funding round?
SciBac, Inc.'s most recent funding round was Grant on July 9, 2019.
Who are the main investors in SciBac, Inc.?
Key investors in SciBac, Inc. include CARB-X, Breakout Ventures, National Institutes of Health (NIH).
Will SciBac, Inc. IPO soon?
No public IPO plans have been announced for SciBac, Inc..
How can I track SciBac, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SciBac, Inc.'s shares on secondary markets.